Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:NVSNYSEARCA:XLV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVSNovartis$112.45-0.3%$109.86$96.06▼$120.92$237.54B0.61.59 million shs1.69 million shsXLVHealth Care Select Sector SPDR Fund$130.55-0.8%$138.28$127.35▼$159.64$34.55B0.688.12 million shs12.72 million shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVSNovartis+0.44%+7.24%+2.00%+5.17%+9.68%XLVHealth Care Select Sector SPDR Fund-2.32%+2.18%-0.75%-10.62%-10.03%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNVSNovartis1.3665 of 5 stars1.03.02.50.02.30.01.9XLVHealth Care Select Sector SPDR FundN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNVSNovartis 2.00Hold$123.389.72% UpsideXLVHealth Care Select Sector SPDR Fund 2.71Moderate Buy$130.55N/ACurrent Analyst Ratings BreakdownLatest NVS and XLV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/15/2025NVSNovartisBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 5/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNVSNovartis$53.22B4.46$11.21 per share10.03$21.59 per share5.21XLVHealth Care Select Sector SPDR FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNVSNovartis$11.94B$6.4019.1212.761.7023.56%37.24%15.85%7/17/2025 (Estimated)XLVHealth Care Select Sector SPDR FundN/AN/A27.62∞N/AN/AN/AN/AN/ALatest NVS and XLV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/29/2025Q1 2025NVSNovartis$2.12$2.28+$0.16$1.83$12.92 billion$13.23 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNVSNovartis$2.592.30%+5.34%40.47%N/AXLVHealth Care Select Sector SPDR Fund$2.341.79%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNVSNovartis0.481.040.84XLVHealth Care Select Sector SPDR FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNVSNovartis13.12%XLVHealth Care Select Sector SPDR FundN/AInsider OwnershipCompanyInsider OwnershipNVSNovartis0.01%XLVHealth Care Select Sector SPDR FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNVSNovartis101,7002.11 billion2.04 billionOptionableXLVHealth Care Select Sector SPDR FundN/A264.62 millionN/ANot OptionableNVS and XLV HeadlinesRecent News About These CompaniesInvestors Purchase High Volume of Call Options on Health Care Select Sector SPDR Fund (NYSEARCA:XLV)May 17, 2025 | americanbankingnews.comInvestors Buy High Volume of Put Options on Health Care Select Sector SPDR Fund (NYSEARCA:XLV)May 16, 2025 | americanbankingnews.comPalantir Soars 500% In A Year While UnitedHealth Tanks 40% — Tech Leaves Healthcare In The DustMay 15, 2025 | benzinga.comHealthcare ETFs Slide as UnitedHealth PlungesMay 13, 2025 | finance.yahoo.comTop Analyst-Rated Healthcare Stocks to Watch Now (XLV)May 11, 2025 | marketbeat.comSPDR Health Care Select Sector (XLV)May 11, 2025 | uk.investing.comHealthcare stocks that could be poised for a reboundMay 9, 2025 | msn.comUpbeat April Jobs Data Put Focus on 3 Sector ETFs & StocksMay 7, 2025 | zacks.comTop 3 Sectors Where Valuations Are Most Below Market Levels (XLV)May 6, 2025 | marketbeat.comHealthcare sector flexes earnings muscle, but top-line cracks showMay 3, 2025 | msn.comInvest in These ETFs to Prepare Your Portfolio for a RecessionMay 3, 2025 | fool.comIs Healthcare Losing the Status of Safe Haven? ETFs in FocusApril 30, 2025 | zacks.comHealth Care Sector In 2025: Buy Abbott LabsApril 28, 2025 | forbes.comBuy Healthcare Stocks Despite RFK Jr., Tariffs, and UnitedHealthApril 25, 2025 | msn.com5 Sector ETFs Set for Q1 Earnings Growth Amid Tariff WoesApril 11, 2025 | zacks.comShould You Invest in the Health Care Select Sector SPDR ETF (XLV)?April 10, 2025 | zacks.comShould You Invest in the Health Care Select Sector SPDR ETF (XLV)?April 10, 2025 | zacks.comHealthcare Stocks Aren’t a Shelter From the Tariff StormApril 9, 2025 | msn.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comHealthcare Stocks Aren't a Shelter From the Tariff StormApril 9, 2025 | barrons.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNVS and XLV Company DescriptionsNovartis NYSE:NVS$112.45 -0.33 (-0.29%) Closing price 03:59 PM EasternExtended Trading$111.88 -0.57 (-0.51%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.Health Care Select Sector SPDR Fund NYSEARCA:XLV$130.55 -1.03 (-0.78%) Closing price 04:10 PM EasternExtended Trading$130.76 +0.20 (+0.16%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O These 4 Top Investors Bought Over 6 Million Broadcom Shares in Q1 Cathie Wood Just Bought a New Stake in Taiwan Semiconductor Stock Super Micro Computer Stock Clears New Path Higher on Saudi Orders Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith? Why Carnival Could Be the Ultimate Non-Tech Growth Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
